Metformin use was linked to a reduced rate of medial cartilage loss that may, in turn, reduce the risk for total knee replacement among patients with osteoarthritis who are obese, according to data published in Arthritis Research & Therapy. “Current treatments for osteoarthritis are modestly effective in pain relief with short-term effects, with no treatments that slow disease … Continue reading Metformin reduces risk of knee OA progression in patients with obesity